Gut hormone polyagonists for the treatment of type 2 diabetes.

about

Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

P2860

Q58705640-08EF7447-7382-413C-8422-55B32042D526 Q59136513-D92AFB75-E468-42A9-A8D0-91B38CA2E168

P2860

Gut hormone polyagonists for the treatment of type 2 diabetes.

Item

http://www.wikidata.org/entity/Q49218095

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Gut hormone polyagonists for the treatment of type 2 diabetes.

@en

Gut hormone polyagonists for the treatment of type 2 diabetes.

@nl

type

Item

label

Gut hormone polyagonists for the treatment of type 2 diabetes.

@en

Gut hormone polyagonists for the treatment of type 2 diabetes.

@nl

prefLabel

Gut hormone polyagonists for the treatment of type 2 diabetes.

@en

Gut hormone polyagonists for the treatment of type 2 diabetes.

@nl

P1476

Gut hormone polyagonists for the treatment of type 2 diabetes.

@en

P2093

Anna Götz

http://www.w3.org/2001/XMLSchema#string

Sara J Brandt

http://www.w3.org/2001/XMLSchema#string

Timo D Müller

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality

Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity

Thyroid hormones and skeletal muscle--new insights and potential implications

Pharmacology, physiology, and mechanisms of incretin hormone action

Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor

P304

190-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.PEPTIDES.2017.12.021

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Tschöp

P5008

ScienceSource

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29412819

http://www.w3.org/2001/XMLSchema#string

P921

maturity-onset diabetes of the young

nerve tissue proteins

P932

5805859

http://www.w3.org/2001/XMLSchema#string

Gut hormone polyagonists for the treatment of type 2 diabetes.

about

P2860

P2860

Gut hormone polyagonists for the treatment of type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P50

P5008

P577

P698

P921

P932